New Same-Day test could revolutionize cervical cancer screening in Low-Resource areas

NCT ID NCT07550010

First seen Apr 29, 2026 · Last updated Apr 29, 2026

Summary

This study evaluates a same-day cervical cancer screening approach for women in Cameroon. Participants aged 30-49 (or 25-49 if HIV-positive) will first test themselves for HPV. Those who test positive will receive a digital analysis of cervical cells on the same day to decide if treatment is needed. The goal is to see if this fast, all-in-one strategy can accurately detect precancerous changes and be practical in low-resource settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING METHODS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier Universitaire de Yaoundé

    RECRUITING

    Yaoundé, Cameroon

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yaoundé University Teaching Hospital (CHU)

    RECRUITING

    Yaoundé, Cameroon

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.